Cita APA

Riancho-Zarrabeitia, L., Martinez-Taboada, V., Rua-Figueroa, I., Alonso, F., Galindo-Izquierdo, M., Ovalles, J., . . . Pego-Reigosa, J. (2020). Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.

Citación estilo Chicago

Riancho-Zarrabeitia, L., et al. Antiphospholipid Syndrome (APS) in Patients With Systemic Lupus Erythematosus (SLE) Implies a More Severe Disease With More Damage Accrual and Higher Mortality. 2020.

Cita MLA

Riancho-Zarrabeitia, L., et al. Antiphospholipid Syndrome (APS) in Patients With Systemic Lupus Erythematosus (SLE) Implies a More Severe Disease With More Damage Accrual and Higher Mortality. 2020.